Read more stories about Public Companies, Indian Unicorns and Telecom in our narratives. View All Narratives

Aggrovation

Bayer-Monsanto: Are they coming for our seeds?

Monsanto and Bayer have merged to form the world's—and India's—largest seed and chemicals company. No one here can challenge their research prowess. No one's trying

07/08/18

Gayathri Vaidyanathan

On 22 May, the CCI conditionally approved Bayer’s acquisition of controversial agri-biotech company Monsanto

With this acquisition, 61% of the global seed and pesticide market will be in the hands of three companies

Indian seed companies are not worried, but should they be?

MNCs are the drivers of innovation at a time global agriculture is undergoing a major disruption

opt_baysanto-1920x1080.jpg

Want to read a free 200 word summary?

Big Ag just became humongous. On 4 July, Bayer AG, the German multinational pharma company, bought the world’s most controversial agriculture company, Monsanto, in a $66-billion deal that gave Bayer control over a whopping 30% of the global seed market and a quarter of the pesticide market. The merger, two years in the making, is…

Read more stories about Public Companies, Indian Unicorns and Telecom in our narratives. Or see all narratives

Read the full story. Subscribe now.

Also read our exhaustive coverage about Public Companies, Indian Unicorns and Telecom

Why subscribe? Let us explain.

Already Registered?

Related stories

More stories in /Reportage & /Technology

See all in Business, Startups & Technology

This story is for subscribers only.
or

Read the full story. Subscribe now.

Also read our exhaustive coverage about Public Companies, Indian Unicorns and Telecom

Why subscribe? Let us explain.

The selected story is available only for paid subscribers. Might want to change your mind!

Subscribe now

Already Registered?

Questions?

What is The Ken?

The Ken is a subscription-driven media site. We write one story a day (weekdays only). These stories have sharp, original insights on technology, business, science and healthcare from India.

Why do I have to sign up to read your stories?

Our stories are not free. Well, some select stories are. But, a significant part of what we write at The Ken is for subscribers only. We put in a lot of effort and resources in writing our stories and believe that you must pay for good journalism.
Hence, our three plans. 1) The annual membership
2) The free sign up
3) The recurring quarterly subscription

On journalism and why you should pay for it, if you haven’t already seen it, here’s a great explainer from John Oliver.

So, one must pay for journalism?

Yes.

How many stories will I get if I take an annual membership?

200+ stories.

And, in the free sign up?

Four stories every month.

Do I get a refund?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am not getting my daily emails. Do I have to whitelist emails from The Ken?

An added benefit of your subscription (free/paid) are the daily personalised emails. These emails, at times, might end up in your spam/junk folder due to emojis, attachments or images. In case you’re not receiving these emails, it might help to whitelist us. If the problem still persists, write to us at [email protected].

Why am I unable to access the archives?

Full and unrestricted access to our archives is a feature of our annual membership.

My payment is not going through, what can I do?

Please write to us at [email protected] detailing the payment error or queries.

See all FAQs

    See all results for Ken

    No results found for Ken.